SE520645C2 - Terapeutiska och kosmetiska kompositioner, deras användning och metod för framställning därav - Google Patents

Terapeutiska och kosmetiska kompositioner, deras användning och metod för framställning därav

Info

Publication number: SE520645C2
Authority: SE; Sweden
Prior art keywords: component; composition according; cyclodextrin; skin; beta
Prior art date: 1996-11-15

Application number

SE9604193A

Other languages

English (en)

Swedish (sv)

Other versions

SE9604193L (sv

SE9604193D0 (sv

Inventor

Lars Kaernerud

Stellan Oelmeskog

Ingemar Naeslund

Original Assignee

Interhealth Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-11-15

Filing date

1996-11-15

Publication date

2003-08-05

1996-11-15 Application filed by Interhealth Ab filed Critical Interhealth Ab

1996-11-15 Priority to SE9604193A priority Critical patent/SE520645C2/sv

1996-11-15 Publication of SE9604193D0 publication Critical patent/SE9604193D0/xx

1997-11-14 Priority to NZ335473A priority patent/NZ335473A/en

1997-11-14 Priority to DE69727507T priority patent/DE69727507T2/de

1997-11-14 Priority to AU50773/98A priority patent/AU727291B2/en

1997-11-14 Priority to EP97913636A priority patent/EP1014926B1/de

1997-11-14 Priority to IL12953697A priority patent/IL129536A0/xx

1997-11-14 Priority to PCT/SE1997/001921 priority patent/WO1998022083A1/en

1997-11-14 Priority to CA002271268A priority patent/CA2271268C/en

1997-11-14 Priority to AT97913636T priority patent/ATE258783T1/de

1997-11-14 Priority to PL97333209A priority patent/PL333209A1/xx

1998-05-16 Publication of SE9604193L publication Critical patent/SE9604193L/xx

1999-04-28 Priority to NO19992030A priority patent/NO313616B1/no

2003-08-05 Publication of SE520645C2 publication Critical patent/SE520645C2/sv

Links

239000000203 mixture Substances 0.000 title claims abstract description 46
239000002537 cosmetic Substances 0.000 title claims abstract description 10
238000000034 method Methods 0.000 title claims abstract description 10
238000002360 preparation method Methods 0.000 title abstract description 6
230000001225 therapeutic effect Effects 0.000 title description 7
PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims abstract description 24
YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 claims abstract description 18
BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 claims abstract description 18
229940031439 squalene Drugs 0.000 claims abstract description 18
TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 claims abstract description 18
150000001720 carbohydrates Chemical class 0.000 claims abstract description 11
235000014633 carbohydrates Nutrition 0.000 claims abstract description 11
239000010686 shark liver oil Substances 0.000 claims abstract description 11
229940069764 shark liver oil Drugs 0.000 claims abstract description 11
239000004480 active ingredient Substances 0.000 claims abstract description 3
229920000858 Cyclodextrin Polymers 0.000 claims description 24
239000002674 ointment Substances 0.000 claims description 14
239000001116 FEMA 4028 Substances 0.000 claims description 13
WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 13
235000011175 beta-cyclodextrine Nutrition 0.000 claims description 13
229960004853 betadex Drugs 0.000 claims description 13
150000001875 compounds Chemical class 0.000 claims description 9
-1 alkyl glycerols Chemical class 0.000 claims description 6
239000006071 cream Substances 0.000 claims description 6
230000015572 biosynthetic process Effects 0.000 claims description 5
239000013522 chelant Substances 0.000 claims description 5
238000010438 heat treatment Methods 0.000 claims description 5
230000002209 hydrophobic effect Effects 0.000 claims description 5
238000003756 stirring Methods 0.000 claims description 5
235000011187 glycerol Nutrition 0.000 claims description 4
230000037303 wrinkles Effects 0.000 claims description 4
230000032683 aging Effects 0.000 claims description 3
239000003814 drug Substances 0.000 claims description 3
239000012456 homogeneous solution Substances 0.000 claims description 3
239000006210 lotion Substances 0.000 claims description 3
229920001450 Alpha-Cyclodextrin Polymers 0.000 claims description 2
206010061218 Inflammation Diseases 0.000 claims description 2
HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 claims description 2
229940043377 alpha-cyclodextrin Drugs 0.000 claims description 2
GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 claims description 2
229940080345 gamma-cyclodextrin Drugs 0.000 claims description 2
230000004054 inflammatory process Effects 0.000 claims description 2
238000002156 mixing Methods 0.000 claims description 2
239000000843 powder Substances 0.000 claims description 2
208000017520 skin disease Diseases 0.000 claims description 2
230000000699 topical effect Effects 0.000 claims description 2
238000004519 manufacturing process Methods 0.000 claims 2
208000032544 Cicatrix Diseases 0.000 claims 1
231100000241 scar Toxicity 0.000 claims 1
230000037387 scars Effects 0.000 claims 1
150000004697 chelate complex Chemical class 0.000 abstract description 4
239000013543 active substance Substances 0.000 abstract description 3
JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 abstract description 3
229940032094 squalane Drugs 0.000 abstract description 3
230000000694 effects Effects 0.000 description 11
230000005855 radiation Effects 0.000 description 9
238000001959 radiotherapy Methods 0.000 description 7
YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 6
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
230000009286 beneficial effect Effects 0.000 description 5
HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 5
239000008346 aqueous phase Substances 0.000 description 4
230000000536 complexating effect Effects 0.000 description 4
230000002496 gastric effect Effects 0.000 description 4
239000000126 substance Substances 0.000 description 4
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
206010028980 Neoplasm Diseases 0.000 description 3
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
239000004615 ingredient Substances 0.000 description 3
150000002632 lipids Chemical class 0.000 description 3
239000003921 oil Substances 0.000 description 3
235000019198 oils Nutrition 0.000 description 3
FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 3
239000012071 phase Substances 0.000 description 3
229960004889 salicylic acid Drugs 0.000 description 3
230000029663 wound healing Effects 0.000 description 3
208000003251 Pruritus Diseases 0.000 description 2
240000008042 Zea mays Species 0.000 description 2
235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
235000002017 Zea mays subsp mays Nutrition 0.000 description 2
239000002671 adjuvant Substances 0.000 description 2
OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 2
201000011510 cancer Diseases 0.000 description 2
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
238000010668 complexation reaction Methods 0.000 description 2
235000005822 corn Nutrition 0.000 description 2
229940097362 cyclodextrins Drugs 0.000 description 2
239000000645 desinfectant Substances 0.000 description 2
201000010099 disease Diseases 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
239000006185 dispersion Substances 0.000 description 2
230000009931 harmful effect Effects 0.000 description 2
230000000622 irritating effect Effects 0.000 description 2
230000007803 itching Effects 0.000 description 2
230000003647 oxidation Effects 0.000 description 2
238000007254 oxidation reaction Methods 0.000 description 2
230000000144 pharmacologic effect Effects 0.000 description 2
230000003449 preventive effect Effects 0.000 description 2
230000000069 prophylactic effect Effects 0.000 description 2
239000000243 solution Substances 0.000 description 2
235000000346 sugar Nutrition 0.000 description 2
150000008163 sugars Chemical class 0.000 description 2
231100000419 toxicity Toxicity 0.000 description 2
230000001988 toxicity Effects 0.000 description 2
OOWQBDFWEXAXPB-IBGZPJMESA-N 1-O-hexadecyl-sn-glycerol Chemical compound CCCCCCCCCCCCCCCCOC[C@@H](O)CO OOWQBDFWEXAXPB-IBGZPJMESA-N 0.000 description 1
WJFKNYWRSNBZNX-UHFFFAOYSA-N 10H-phenothiazine Chemical compound C1=CC=C2NC3=CC=CC=C3SC2=C1 WJFKNYWRSNBZNX-UHFFFAOYSA-N 0.000 description 1
NRWMBHYHFFGEEC-MDZDMXLPSA-N 3-[(e)-octadec-9-enoxy]propane-1,2-diol Chemical compound CCCCCCCC\C=C\CCCCCCCCOCC(O)CO NRWMBHYHFFGEEC-MDZDMXLPSA-N 0.000 description 1
241000271566 Aves Species 0.000 description 1
229920002261 Corn starch Polymers 0.000 description 1
201000004624 Dermatitis Diseases 0.000 description 1
206010012438 Dermatitis atopic Diseases 0.000 description 1
206010019233 Headaches Diseases 0.000 description 1
206010020751 Hypersensitivity Diseases 0.000 description 1
241000699670 Mus sp. Species 0.000 description 1
208000008469 Peptic Ulcer Diseases 0.000 description 1
201000004681 Psoriasis Diseases 0.000 description 1
241000700159 Rattus Species 0.000 description 1
206010052428 Wound Diseases 0.000 description 1
208000027418 Wounds and injury Diseases 0.000 description 1
238000005299 abrasion Methods 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
150000001298 alcohols Chemical class 0.000 description 1
208000026935 allergic disease Diseases 0.000 description 1
230000007815 allergy Effects 0.000 description 1
201000008937 atopic dermatitis Diseases 0.000 description 1
208000010668 atopic eczema Diseases 0.000 description 1
IWWCATWBROCMCW-UHFFFAOYSA-N batyl alcohol Natural products CCCCCCCCCCCCCCCCCCOC(O)CO IWWCATWBROCMCW-UHFFFAOYSA-N 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
QRZAKQDHEVVFRX-UHFFFAOYSA-N biphenyl-4-ylacetic acid Chemical compound C1=CC(CC(=O)O)=CC=C1C1=CC=CC=C1 QRZAKQDHEVVFRX-UHFFFAOYSA-N 0.000 description 1
238000009835 boiling Methods 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
OOWQBDFWEXAXPB-UHFFFAOYSA-N chimyl alcohol Natural products CCCCCCCCCCCCCCCCOCC(O)CO OOWQBDFWEXAXPB-UHFFFAOYSA-N 0.000 description 1
ZPEIMTDSQAKGNT-UHFFFAOYSA-N chlorpromazine Chemical compound C1=C(Cl)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZPEIMTDSQAKGNT-UHFFFAOYSA-N 0.000 description 1
229960001076 chlorpromazine Drugs 0.000 description 1
235000012000 cholesterol Nutrition 0.000 description 1
230000009918 complex formation Effects 0.000 description 1
239000008120 corn starch Substances 0.000 description 1
230000002596 correlated effect Effects 0.000 description 1
231100000673 dose–response relationship Toxicity 0.000 description 1
229940079593 drug Drugs 0.000 description 1
238000010894 electron beam technology Methods 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
239000003623 enhancer Substances 0.000 description 1
BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
239000003925 fat Substances 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
239000000834 fixative Substances 0.000 description 1
238000009472 formulation Methods 0.000 description 1
125000000524 functional group Chemical group 0.000 description 1
231100000869 headache Toxicity 0.000 description 1
230000035876 healing Effects 0.000 description 1
238000005984 hydrogenation reaction Methods 0.000 description 1
210000000987 immune system Anatomy 0.000 description 1
230000002757 inflammatory effect Effects 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
238000010255 intramuscular injection Methods 0.000 description 1
239000007927 intramuscular injection Substances 0.000 description 1
239000002085 irritant Substances 0.000 description 1
230000007794 irritation Effects 0.000 description 1
210000003205 muscle Anatomy 0.000 description 1
239000003176 neuroleptic agent Substances 0.000 description 1
230000000701 neuroleptic effect Effects 0.000 description 1
239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
229920001542 oligosaccharide Polymers 0.000 description 1
150000002482 oligosaccharides Chemical class 0.000 description 1
238000011275 oncology therapy Methods 0.000 description 1
230000035515 penetration Effects 0.000 description 1
239000002304 perfume Substances 0.000 description 1
229950000688 phenothiazine Drugs 0.000 description 1
QYSPLQLAKJAUJT-UHFFFAOYSA-N piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 description 1
229960002702 piroxicam Drugs 0.000 description 1
239000002243 precursor Substances 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
229910052705 radium Inorganic materials 0.000 description 1
HCWPIIXVSYCSAN-UHFFFAOYSA-N radium atom Chemical compound [Ra] HCWPIIXVSYCSAN-UHFFFAOYSA-N 0.000 description 1
NRWMBHYHFFGEEC-UHFFFAOYSA-N selachyl alcohol Natural products CCCCCCCCC=CCCCCCCCCOCC(O)CO NRWMBHYHFFGEEC-UHFFFAOYSA-N 0.000 description 1
230000009759 skin aging Effects 0.000 description 1
229940075582 sorbic acid Drugs 0.000 description 1
235000010199 sorbic acid Nutrition 0.000 description 1
239000004334 sorbic acid Substances 0.000 description 1
150000003431 steroids Chemical class 0.000 description 1
208000024891 symptom Diseases 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
238000011200 topical administration Methods 0.000 description 1
231100000041 toxicology testing Toxicity 0.000 description 1
229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
229960005486 vaccine Drugs 0.000 description 1
235000015112 vegetable and seed oil Nutrition 0.000 description 1
239000008158 vegetable oil Substances 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/738—Cyclodextrins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/925—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of animal origin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/004—Aftersun preparations

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Birds (AREA)
Dermatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nanotechnology (AREA)
Biotechnology (AREA)
Marine Sciences & Fisheries (AREA)
Crystallography & Structural Chemistry (AREA)
General Engineering & Computer Science (AREA)
Biophysics (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Medical Informatics (AREA)
Zoology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Gerontology & Geriatric Medicine (AREA)
Medicinal Preparation (AREA)
Cosmetics (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

SE9604193A 1996-11-15 1996-11-15 Terapeutiska och kosmetiska kompositioner, deras användning och metod för framställning därav SE520645C2 (sv)

Priority Applications (11)

Application Number	Priority Date	Filing Date	Title
SE9604193A SE520645C2 (sv)	1996-11-15	1996-11-15	Terapeutiska och kosmetiska kompositioner, deras användning och metod för framställning därav
PL97333209A PL333209A1 (en)	1996-11-15	1997-11-14	Medical and cosmetic compositions, their applications and method of manufacturing
EP97913636A EP1014926B1 (de)	1996-11-15	1997-11-14	Therapeutische und kosmetische mittel, ihre verwendung und herstellungsverfahren
DE69727507T DE69727507T2 (de)	1996-11-15	1997-11-14	Therapeutische und kosmetische mittel, ihre verwendung und herstellungsverfahren
AU50773/98A AU727291B2 (en)	1996-11-15	1997-11-14	Therapeutic and cosmetic compositions, their use and method for the preparation thereof
NZ335473A NZ335473A (en)	1996-11-15	1997-11-14	Therapeutic and cosmetic compositions, their use and method for the preparation thereof
IL12953697A IL129536A0 (en)	1996-11-15	1997-11-14	Therapeutic and cosmetic compositions their use and method for the preparation thereof
PCT/SE1997/001921 WO1998022083A1 (en)	1996-11-15	1997-11-14	Therapeutic and cosmetic compositions, their use and method for the preparation thereof
CA002271268A CA2271268C (en)	1996-11-15	1997-11-14	Therapeutic and cosmetic compositions comprising an extract of crude shark liver oil, their use and method for the preparation thereof
AT97913636T ATE258783T1 (de)	1996-11-15	1997-11-14	Therapeutische und kosmetische mittel, ihre verwendung und herstellungsverfahren
NO19992030A NO313616B1 (no)	1996-11-15	1999-04-28	Terapeutiske og kosmetiske sammensetninger og deres anvendelse

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE9604193A SE520645C2 (sv)	1996-11-15	1996-11-15	Terapeutiska och kosmetiska kompositioner, deras användning och metod för framställning därav

Publications (3)

Publication Number	Publication Date
SE9604193D0 SE9604193D0 (sv)	1996-11-15
SE9604193L SE9604193L (sv)	1998-05-16
SE520645C2 true SE520645C2 (sv)	2003-08-05

Family

ID=20404626

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE9604193A SE520645C2 (sv)	1996-11-15	1996-11-15	Terapeutiska och kosmetiska kompositioner, deras användning och metod för framställning därav

Country Status (11)

Country	Link
EP (1)	EP1014926B1 (de)
AT (1)	ATE258783T1 (de)
AU (1)	AU727291B2 (de)
CA (1)	CA2271268C (de)
DE (1)	DE69727507T2 (de)
IL (1)	IL129536A0 (de)
NO (1)	NO313616B1 (de)
NZ (1)	NZ335473A (de)
PL (1)	PL333209A1 (de)
SE (1)	SE520645C2 (de)
WO (1)	WO1998022083A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9801647D0 (sv)	1998-05-12	1998-05-12	Interhealth Ab	Therapeutic composition
FR2782269B1 (fr) *	1998-08-17	2001-08-31	Oreal	Composition cosmetique et/ou dermatologique contenant de l'acide salicylique ou un derive d'acide salicylique et son utilisation
WO2000012137A1 (en) *	1998-09-02	2000-03-09	Allergan Sales, Inc.	Preserved cyclodextrin-containing compositions
JP2000159678A (ja) *	1998-11-30	2000-06-13	Nof Corp	皮膚外用剤組成物
US7090859B2 (en)	2002-12-13	2006-08-15	Ronald Thomas Haas	Ketoprofen compositions and methods of making them
GB0519334D0 (en) *	2005-09-22	2005-11-02	Unichema Chemie Bv	Method and composition for treating skin
FR3017796B1 (fr) *	2014-02-27	2017-03-24	Etienne Soudant	Composition cosmetique a base de squalene comme substitut incolore aux carotenoides

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3294639A (en) *	1964-02-03	1966-12-27	Eversharp Inc	Treatment of inflammatory diseases
JPS61227517A (ja) *	1985-04-01	1986-10-09	Lion Corp	皮膚化粧料
CA1321192C (en) *	1988-04-20	1993-08-10	Abdul Majid	Inclusion complexes of cyclodextrins by agglomeration
AU616571B2 (en) *	1988-10-28	1991-10-31	Shiseido Company Ltd.	Cosmetic composition containing inclusion product with hydroxyalkylated cyclodextrin
JP2954634B2 (ja) *	1990-02-13	1999-09-27	協和醗酵工業株式会社	化粧料
US5079003A (en) *	1990-03-14	1992-01-07	Adelia Scaffidi	Skin lotions and creams
SE9300971D0 (sv) *	1993-03-24	1993-03-24	Jan Wadstein	Hudvaardskomposition

1996
- 1996-11-15 SE SE9604193A patent/SE520645C2/sv not_active IP Right Cessation
1997
- 1997-11-14 WO PCT/SE1997/001921 patent/WO1998022083A1/en not_active Ceased
- 1997-11-14 PL PL97333209A patent/PL333209A1/xx unknown
- 1997-11-14 AT AT97913636T patent/ATE258783T1/de not_active IP Right Cessation
- 1997-11-14 CA CA002271268A patent/CA2271268C/en not_active Expired - Fee Related
- 1997-11-14 IL IL12953697A patent/IL129536A0/xx unknown
- 1997-11-14 AU AU50773/98A patent/AU727291B2/en not_active Ceased
- 1997-11-14 DE DE69727507T patent/DE69727507T2/de not_active Expired - Fee Related
- 1997-11-14 EP EP97913636A patent/EP1014926B1/de not_active Expired - Lifetime
- 1997-11-14 NZ NZ335473A patent/NZ335473A/en unknown
1999
- 1999-04-28 NO NO19992030A patent/NO313616B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
SE9604193L (sv)	1998-05-16
NZ335473A (en)	2001-02-23
NO992030D0 (no)	1999-04-28
DE69727507D1 (de)	2004-03-11
DE69727507T2 (de)	2004-12-16
IL129536A0 (en)	2000-02-29
PL333209A1 (en)	1999-11-22
ATE258783T1 (de)	2004-02-15
NO992030L (no)	1999-04-28
CA2271268C (en)	2008-07-08
AU727291B2 (en)	2000-12-07
CA2271268A1 (en)	1998-05-28
EP1014926A1 (de)	2000-07-05
SE9604193D0 (sv)	1996-11-15
EP1014926B1 (de)	2004-02-04
WO1998022083A1 (en)	1998-05-28
AU5077398A (en)	1998-06-10
NO313616B1 (no)	2002-11-04

Legal Events

Date	Code	Title	Description
2010-06-29	NUG	Patent has lapsed

Publication	Publication Date	Title
US9833461B2 (en)	2017-12-05	Therapeutic compositions comprising cannabidiol and corticosteroids
CA2910206C (en)	2016-12-13	Novel therapeutic composition
US20100261670A1 (en)	2010-10-14	Complexes of phosphate derivatives
AU752586B2 (en)	2002-09-26	Therapeutic compositions
JPH05286864A (ja)	1993-11-02	乾癬及びアトピー性皮膚炎治療用の局所適用製剤
EP1014926B1 (de)	2004-02-04	Therapeutische und kosmetische mittel, ihre verwendung und herstellungsverfahren
CN104684538B (zh)	2017-07-21	用于皮肤保湿的化妆品或皮肤病学组合物
KR102057091B1 (ko)	2019-12-18	Nrf2 인덕션 리바이탈라이징 제제용 피이지프리 가용화제, 이를 포함하는 Nrf2 인덕션 리바이탈라이징 제제, 이를 포함하는 화장품 및 이의 제조방법
EP0020532B1 (de)	1983-07-13	Haut-zusammensetzung auf der basis von lezithin-triäthanolamin
JPH04360820A (ja)	1992-12-14	化粧料
JP3326059B2 (ja)	2002-09-17	皮膚化粧料
US10548939B1 (en)	2020-02-04	Oat and marigold based composition with anti-inflammatory and wound healing action and method of preparing same
JP3556894B2 (ja)	2004-08-25	皮膚外用剤
CN115209890B (zh)	2024-12-17	抑制促炎基因表达的紫草素、芳基萘木酚素以及包含它们的药物组合物
JP3813515B2 (ja)	2006-08-23	洗い流し型化粧料
KR100473716B1 (ko)	2005-03-08	7-디하이드로콜레스테롤 및 사이클로덱스트린의 포접복합체, 이를 포함하는 화장료 조성물 및7-디하이드로콜레스테롤의 안정화방법
JP2005281174A (ja)	2005-10-13	活性酸素消去剤
JP5311699B2 (ja)	2013-10-09	皮膚外用剤
KR20220056731A (ko)	2022-05-06	칼라민을 포함하는 화장료 조성물 및 이의 제조방법
KR20220060036A (ko)	2022-05-11	케라틴을 함유하는 항염증 조성물
JPH01113314A (ja)	1989-05-02	皮膚外用剤
JP2004002281A (ja)	2004-01-08	液状化粧料
CZ294004B6 (cs)	2004-09-15	Léčivé a kosmetické přípravky pro topickou aplikaci
JP2005015389A (ja)	2005-01-20	皮膚外用剤
HK1037126B (en)	2005-12-02	Compositions for the treatment of acne